Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

CUSIP: 005111109

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 5 signals
Share change
-1,000
SEC-reported price per share
$0.04
Indexed holders
1
Value change
-$43
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,359,615

Security key

005111109

Report period

Q1 2025

Indexed institutions

1

Top holders

1

Ownership snapshot

Top reported holders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
James E. Flynn
Disclosed value leader
James E. Flynn
Comparable rows
1/15
Latest evidence
27 Jan 2025
3/4/5 13D/G Lead comparable stake: 9.1% 14 rows are not safely comparable across share classes. 13D/G row: James E. Flynn Showing 1-6 of 15 holder rows.

Quick read

James E. Flynn leads the comparable SEC ownership view at 9.1%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens James E. Flynn's linked filing trail.
Comparable ownership Top 1
James E. Flynn 9.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
James E. Flynn
3/4/5 13D/G
Director, Director by deputization
9.1%
Reported 13D/G · 27 Jan 2025
$4,163,964
5,434,049 shares
mixed-class rows
— 27 Jan 2025
ORBIMED ADVISORS LLC
3/4/5
Director, 10%+ Owner
—
denominator unverified
$2,616,683
1,677,361 shares
— 19 Jul 2021
Shahzad Malik
3/4/5
Director
—
mixed-class rows
$2,426,946
1,562,757 shares
mixed-class rows
— 17 Jun 2021
James F. Hinrichs.
3/4/5
Director
—
mixed-class rows
$119,043
95,910 shares
mixed-class rows
— 16 Jun 2022
Richard Scott Huennekens
3/4/5
Director
—
denominator unverified
$100,047
529,349 shares
— 15 Jun 2023
Vincent J. Burgess
3/4/5
Chief Executive Officer, Director
—
denominator unverified
$95,892
61,469 shares
— 01 Apr 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
1
Shares
2,000
Indexed holders
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 indexed holders
1
Q1 2025 indexed holders
1
Indexed holder difference
0
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 value Q1 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .